ClinicalTrials.govpublic full text
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
hiv-1, hiv-1 nnrti treatment experienced, may have protease inhibitor experience, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 827529
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.